Abstract:Huntington's disease is a neurodegenerative disease caused by the expansion mutation of a cytosine-adenine-guanine triplet in the exon 1 of the HTT gene which is responsible for the production of the huntingtin (Htt) protein. In physiological conditions, Htt is involved in many cellular processes such as cell signaling, transcriptional regulation, energy metabolism regulation, DNA maintenance, axonal trafficking, and antiapoptotic activity. When the genetic alteration is present, the production of a mutant version of Htt (mHtt) occurs, which is characterized by a plethora of pathogenic activities that, finally, lead to cell death. Among all the cells in which mHtt exerts its dangerous activity, the GABAergic Medium Spiny Neurons seem to be the most affected by the mHtt-induced excitotoxicity both in the cortex and in the striatum. However, as the neurodegeneration proceeds ahead the neuronal loss grows also in other brain areas such as the cerebellum, hypothalamus, thalamus, subthalamic nucleus, globus pallidus, and substantia nigra, determining the variety of symptoms that characterize Huntington's disease. From a clinical point of view, Huntington's disease is characterized by a wide spectrum of symptoms spanning from motor impairment to cognitive disorders and dementia. Huntington's disease shows a prevalence of around 3.92 cases every 100,000 worldwide and an incidence of 0.48 new cases every 100,000/year. To date, there is no available cure for Huntington's disease. Several treatments have been developed so far, aiming to reduce the severity of one or more symptoms to slow down the inexorable decline caused by the disease. In this context, the search for reliable strategies to target the different aspects of Huntington's disease become of the utmost interest. In recent years, a variety of studies demonstrated the detrimental role of neuronal loss in Huntington's disease condition highlighting how the replacement of lost cells would be a reasonable strategy to overcome the neurodegeneration. In this view, numerous have been the attempts in several preclinical models of Huntington's disease to evaluate the feasibility of invasive and non-invasive approaches. Thus, the aim of this review is to offer an overview of the most appealing approaches spanning from stem cell-based cell therapy to extracellular vesicles such as exosomes in light of promoting neurogenesis, discussing the results obtained so far, their limits and the future perspectives regarding the neural regeneration in the context of Huntington's disease.

Neural and mesenchymal stem cells in animal models of Huntington's disease: past experiences and future challenges

Use of human stem cells in Huntington disease modeling and translational research

Therapeutic advances in neural regeneration for Huntington's disease

Stem Cells for the Treatment of Neurodegenerative Diseases

Human cellular models of medium spiny neuron development and Huntington disease

Progress in studies of gene therapy for Huntington's disease

Induced neural stem cells as a means of treatment in Huntington’s disease

Induced Pluripotent Stem Cells in Huntington’s Disease: Disease Modeling and the Potential for Cell-Based Therapy

Neural Transplants from Human Induced Pluripotent Stem Cells Rescue the Pathology and Behavioral Defects in a Rodent Model of Huntington's Disease.

The Role of Stem Cell Therapies in the Treatment of Neurodegenerative Diseases

Stem Cells for Huntington's Disease (SC4HD): an International Consortium to Facilitate Stem Cell-Based Therapy for Huntington's Disease

Combination of stem cell and gene therapy ameliorates symptoms in Huntington's disease mice

Using gene or cell therapies to treat Huntington's disease

Advancements in surgical treatments for Huntington disease: From pallidotomy to experimental therapies

Advances in Gene and Cellular Therapeutic Approaches for Huntington’s Disease

Translating cell therapies for neurodegenerative diseases: Huntington’s disease as a model disorder

Intracerebral Transplantation of BDNF-overexpressing Human Neural Stem Cells (HB1.F3.BDNF) Promotes Migration, Differentiation and Functional Recovery in a Rodent Model of Huntington's Disease.

Huntington Disease: Linking Pathogenesis to the Development of Experimental Therapeutics

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Therapy development in Huntington disease: From current strategies to emerging opportunities

Latest Advances on New Promising Molecular-Based Therapeutic Approaches for Huntington’s Disease